CSIMarket


Alpine Immune Sciences Inc   (ALPN)
Other Ticker:  
 

Alpine Immune Sciences Inc

ALPN's Fundamental analysis








Looking into Alpine Immune Sciences Inc growth rates, revenue grew by 1011.42 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 1743

Major Pharmaceutical Preparations industry recorded deterioration of revenues by

Alpine Immune Sciences Inc realized net income compared to net loss a year ago in IV. Quarter 2023

More on ALPN's Growth


Alpine Immune Sciences Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 61.63 in trailing twelve-month period.
Company
-
PE TTM   
Industry
268.82
PE TTM    
Company's Price to Sales ratio is at 31.99.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.72.


More on ALPN's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,635,444
 Net Income/Employee (TTM) $ -894,000
 Receivable Turnover (TTM) 176.01
 Tangible Book Value (Per Share $) 6.52

Alpine Immune Sciences Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 61.63 in trailing twelve-month period.
Company
-
PE TTM   
Industry
268.82
PE TTM    
Company's Price to Sales ratio is at 31.99.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.72.

Alpine Immune Sciences Inc Price to Book Ratio is at 5.74 lower than Indusry Avg. of 1286.3. and higher than S&P 500 Avg. of 0.01

More on ALPN's Valuation

  Market Capitalization (Millions $) 1,883
  Shares Outstanding (Millions) 50
  Employees 36
  Revenues (TTM) (Millions $) 59
  Net Income (TTM) (Millions $) -32
  Cash Flow (TTM) (Millions $) 31
  Capital Exp. (TTM) (Millions $) 0
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 1,635,444
  Net Income/Employee(TTM) $ -894,000
  Receivable Turnover Ratio (TTM) 176.01
  Tangible Book Value (Per Share $) 6.52

  Market Capitalization (Millions $) 1,883
  Shares Outstanding (Millions) 50
  Employees 36
  Revenues (TTM) (Millions $) 59
  Net Income (TTM) (Millions $) -32
  Cash Flow (TTM) (Millions $) 31
  Capital Exp. (TTM) (Millions $) 0


    ALPN's Profitability Comparisons
Alpine Immune Sciences Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 5.01 %.

Alpine Immune Sciences Inc net profit margin of 19.32 % is currently ranking no. 22 in Major Pharmaceutical Preparations industry, ranking no. 55 in Healthcare sector and number 601 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 7.86
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.16
  Asset Turnover Ratio (TTM) 0.21
  Inventory Turnover Ratio (TTM) -



Alpine Immune Sciences Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 5.01 %.

Alpine Immune Sciences Inc net profit margin of 19.32 % is currently ranking no. 22 in Major Pharmaceutical Preparations industry, ranking no. 55 in Healthcare sector and number 601 in S&P 500.

More on ALPN's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com